Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Janneke Zinkstok"'
Publikováno v:
BJPsych Open, Vol 10, Pp S90-S91 (2024)
Aims The aim of this study is to investigate incident and total benzodiazepine prescribing in the Netherlands during the COVID-19 pandemic, including the impact of lockdown periods. Methods A national Dutch pharmacological registry was used, investi
Externí odkaz:
https://doaj.org/article/121c0caf583a483db4d085e8ca88b971
Autor:
Justo Pinzón-Espinosa, Marte van der Horst, Janneke Zinkstok, Jehannine Austin, Cora Aalfs, Albert Batalla, Patrick Sullivan, Jacob Vorstman, Jurjen J. Luykx
Publikováno v:
Translational Psychiatry, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Genetic testing has evolved rapidly over recent years and new developments have the potential to provide insights that could improve the ability to diagnose, treat, and prevent diseases. Information obtained through genetic testing has prove
Externí odkaz:
https://doaj.org/article/7eea0d6d9c484d1ca2d8ecf1d942d8b3
Autor:
Lessa M. Schippers, Lisa I. Horstman, Hans van de Velde, Rob Rodrigues Pereira, Janneke Zinkstok, Jeanette C. Mostert, Corina U. Greven, Martine Hoogman
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Research in Attention-deficit/hyperactivity disorder (ADHD) has had a clear focus on treatment and the dysfunction in specific situation associated with the condition. However, self-report, observational and anecdotal evidence indicates that there ar
Externí odkaz:
https://doaj.org/article/4982bd3f982e4b7cbda9172addd6280a
Autor:
Nini de Boer, Sinan Guloksuz, Caroline van Baal, Leonie Willebrands, Jeroen Deenik, Christiaan H. Vinkers, Inge Winter-van Rossum, Janneke Zinkstok, Ingeborg Wilting, Jasper B. Zantvoord, Frank Backx, Wilma E. Swildens, Marieke Schouw, Jan Bogers, Folkwin Hulshof, Rudolf de Knijff, Peter Duindam, Mike Veereschild, Maarten Bak, Geert Frederix, Lieuwe de Haan, Jim van Os, Wiepke Cahn, Jurjen J. Luykx
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Antipsychotic-induced Weight Gain (AiWG) is a debilitating and common adverse effect of antipsychotics. AiWG negatively impacts life expectancy, quality of life, treatment adherence, likelihood of developing type-2 diabetes and re
Externí odkaz:
https://doaj.org/article/cf21f7b92b4a4f12ae9ed7e1d9f4014c
Autor:
Amy Lin, Jennifer K. Forsyth, Gil D. Hoftman, Leila Kushan-Wells, Maria Jalbrzikowski, Deepika Dokuru, Giovanni Coppola, Ania Fiksinski, Janneke Zinkstok, Jacob Vorstman, Daniel Nachun, Carrie E. Bearden
Publikováno v:
Brain, Behavior, & Immunity - Health, Vol 18, Iss , Pp 100386- (2021)
22q11.2 reciprocal copy number variants (CNVs) offer a powerful quasi-experimental “reverse-genetics” paradigm to elucidate how gene dosage (i.e., deletions and duplications) disrupts the transcriptome to cause further downstream effects. Clinica
Externí odkaz:
https://doaj.org/article/7bbf0d5c64de4d89987d58b825e1a27b
Autor:
Ania Fiksinski, Janneke Zinkstok, Geertje Ingena Angelique Both, Nanda M. Verhoeven-Duif, Yasmin Namavar, Jacob Abraham Schrey Vorstman, Denise Joanne Duineveld
Publikováno v:
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 186:289-317
Hyperprolinemia Type I and II are genetic metabolic disorders caused by disrupted proline degradation. It has been suggested that hyperprolinemia is associated with increased risk of developmental and mental disorders but detailed information on the
Autor:
Esther D.A. van Duin, Johannes G. Ramaekers, Jacobus F.A. Jansen, Mathilde van Oudenaren, Janneke Zinkstok, Claudia Vingerhoets, Therese van Amelsvoort, Desmond H. Y. Tse, Grainne M. McAlonan, Dennis Hernaus
Publikováno v:
Journal of Psychopharmacology, 34(8):0269881120922977, 856-863. SAGE Publications Ltd
Journal of Psychopharmacology (Oxford, England)
Journal of Psychopharmacology (Oxford, England)
Aims: 22q11.2 deletion syndrome (22q11.2DS) is associated with impaired cognitive functioning. Glutamatergic pathways have been linked with cognition and are hypothesized to be disrupted in 22q11.2DS patients, possibly ‘shifting’ the excitatory (
Autor:
Noboru Hiroi, Therese van Amelsvoort, Erik Boot, Jacob A. S. Vorstman, Claudia Vingerhoets, Janneke Zinkstok, Anne S. Bassett, Nancy J. Butcher
Publikováno v:
The Lancet Psychiatry, 6(11), 951. Elsevier Limited
22q11.2 deletion syndrome is characterised by a well defined microdeletion that is associated with a high risk of neuropsychiatric disorders, including intellectual disability, schizophrenia, attention-deficit hyperactivity disorder, autism spectrum
Publikováno v:
American Journal of Medical Genetics. Part A, 179(11), 2292. Wiley-Liss Inc.
American Journal of Medical Genetics. Part a
American Journal of Medical Genetics. Part a
The 22q11.2 deletion syndrome (22q11.2DS) is a multisystem condition and the most prevalent microdeletion syndrome in humans. Approximately 25% of individuals with 22q11.2DS receive antipsychotic treatment. To assess whether patients with 22q11.2DS a
Autor:
Jennifer K Forsyth, Jacob A. S. Vorstman, Deepika Dokuru, Gil D Hoftman, Giovanni Coppola, Carrie E. Bearden, Ania Fiksinski, Daniel Nachun, Janneke Zinkstok, Leila Kushan-Wells, Maria Jalbrzikowski, Amy Lin
Publikováno v:
Brain, Behavior, & Immunity-Health
Brain, Behavior, & Immunity-Health, Vol 18, Iss, Pp 100386-(2021)
Brain, Behavior, & Immunity-Health, 18. Elsevier Inc.
Brain, Behavior, & Immunity-Health, Vol 18, Iss, Pp 100386-(2021)
Brain, Behavior, & Immunity-Health, 18. Elsevier Inc.
22q11.2 reciprocal copy number variants (CNVs) offer a powerful quasi-experimental "reverse-genetics" paradigm to elucidate how gene dosage (i.e., deletions and duplications) disrupts the transcriptome to cause further downstream effects. Clinical pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb7728a57aba8ff0cadbcb56927b2656
https://escholarship.org/uc/item/2jm858qs
https://escholarship.org/uc/item/2jm858qs